PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q2 2023 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 4,948 | 0.0% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 4,948 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | -99.2% | 4,948 | -98.9% | 0.00% | -100.0% |
Q3 2020 | $1,455,000 | -70.5% | 461,723 | -72.7% | 0.06% | -71.8% |
Q2 2020 | $4,927,000 | -1.7% | 1,693,216 | -4.7% | 0.21% | -11.2% |
Q1 2020 | $5,011,000 | -7.8% | 1,776,784 | +6.1% | 0.23% | +14.9% |
Q4 2019 | $5,435,000 | +594.1% | 1,674,961 | +362.0% | 0.20% | +494.1% |
Q3 2019 | $783,000 | -31.1% | 362,524 | +0.2% | 0.03% | -33.3% |
Q2 2019 | $1,136,000 | -29.0% | 361,878 | -15.9% | 0.05% | -30.1% |
Q1 2019 | $1,601,000 | +16.9% | 430,304 | -8.9% | 0.07% | +10.6% |
Q4 2018 | $1,370,000 | +91.1% | 472,507 | +73.3% | 0.07% | +135.7% |
Q3 2018 | $717,000 | – | 272,707 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |